Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight.
Sachar
D
D
Division of Gastroenterology, Mount Sinai Medical Center, New York City, NY 10029, USA.
D000014:Abnormalities, Drug-Induced; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001724:Birth Weight / Q000187:drug effects*; D016022:Case-Control Studies; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D019804:Mesalamine / Q000009:adverse effects* / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000139:chemically induced*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine